BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eribo OA, Leqheka MS, Malherbe ST, McAnda S, Stanley K, van der Spuy GD, Walzl G, Chegou NN. Host urine immunological biomarkers as potential candidates for the diagnosis of tuberculosis. Int J Infect Dis 2020;99:473-81. [PMID: 32800854 DOI: 10.1016/j.ijid.2020.08.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Khimova E, Gonzalo X, Popova Y, Eliseev P, Andrey M, Nikolayevskyy V, Broda A, Drobniewski F. Urine biomarkers of pulmonary tuberculosis. Expert Rev Respir Med 2022;:1-7. [PMID: 35702997 DOI: 10.1080/17476348.2022.2090341] [Reference Citation Analysis]
2 Namuganga AR, Chegou NN, Mayanja-Kizza H. Past and Present Approaches to Diagnosis of Active Pulmonary Tuberculosis. Front Med (Lausanne) 2021;8:709793. [PMID: 34631731 DOI: 10.3389/fmed.2021.709793] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Mutavhatsindi H, Calder B, McAnda S, Malherbe ST, Stanley K, Kidd M, Walzl G, Chegou NN. Identification of novel salivary candidate protein biomarkers for tuberculosis diagnosis: A preliminary biomarker discovery study. Tuberculosis (Edinb) 2021;130:102118. [PMID: 34371310 DOI: 10.1016/j.tube.2021.102118] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Rezaei M, Mahmoudi S, Mortaz E, Marjani M. Immune cell profiling and antibody responses in patients with COVID-19. BMC Infect Dis 2021;21:646. [PMID: 34225645 DOI: 10.1186/s12879-021-06278-2] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
5 Flores J, Cancino JC, Chavez-Galan L. Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It? Front Microbiol 2021;12:638047. [PMID: 33935997 DOI: 10.3389/fmicb.2021.638047] [Cited by in F6Publishing: 7] [Reference Citation Analysis]